Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

859: Overcoming Current Challenges in Allogeneic Cell Therapy Manufacturing by Using Pooled Donor Cord Blood CD34+ Cells as Starting Material

Disclosures:  C. Stoltzman: None.

Related Abstract

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.